Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$191.89 - $259.92 $832,994 - $1.13 Million
-4,341 Reduced 99.68%
14 $2,000
Q2 2022

Aug 17, 2022

BUY
$204.13 - $302.4 $113,292 - $167,832
555 Added 14.61%
4,355 $932,000
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $19.6 Million - $27.7 Million
-76,600 Reduced 95.27%
3,800 $1.08 Million
Q4 2021

Feb 15, 2022

BUY
$351.38 - $448.68 $26.9 Million - $34.4 Million
76,600 Added 2015.79%
80,400 $30.3 Million
Q3 2021

Nov 18, 2021

BUY
$372.64 - $458.3 $1.42 Million - $1.74 Million
3,800 New
3,800 $1.57 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.65B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.